Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Moodys
Fuji
Cerilliant
Chubb
QuintilesIMS
Covington
Dow
Johnson and Johnson

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019721

« Back to Dashboard

NDA 019721 describes NORDITROPIN, which is a drug marketed by Novo Nordisk Inc and is included in two NDAs. It is available from two suppliers. There are fifteen patents protecting this drug. Additional details are available on the NORDITROPIN profile page.

The generic ingredient in NORDITROPIN is somatropin recombinant. There are four drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the somatropin recombinant profile page.
Summary for 019721
Tradename:NORDITROPIN
Applicant:Novo Nordisk Inc
Ingredient:somatropin recombinant
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength4MG/VIAL
Approval Date:May 8, 1995TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength8MG/VIAL
Approval Date:May 8, 1995TE:RLD:No

Expired US Patents for NDA 019721

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novo Nordisk Inc NORDITROPIN somatropin recombinant INJECTABLE;INJECTION 019721-001 May 8, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Novo Nordisk Inc NORDITROPIN somatropin recombinant INJECTABLE;INJECTION 019721-002 May 8, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Merck
Dow
Johnson and Johnson
Daiichi Sankyo
Citi
QuintilesIMS
Express Scripts
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.